Patented technology regarding new and safe mechanism with the active substance PH3 for the indications of osteoporosis and diabetic vascular complications. More

This ophthalmic solution provides relief of the symptoms associated with dry eye, improving the quality of life among sufferers in both mild-moderate and chronic dry eye cases. More

The present invention provides a potent inhibitor of protein glycation and AGEs formation that is particularly advantageous for eye-drop delivery in the prevention and treatment of diabetes- and age-related pathologies. More

L-histidine is being developed as a prescription drug and as a dietary supplement for 1) chronic inflammatory gastrointestinal diseases; 2) conjunctivitis and seasonal allergic rhinitis; 3) infectious and non-infectious diarrheas; and 4) as an antioxidant More

Indicated specifically for subarachnoid hemorrhage, LPCN 1038 also has potential indications for migraine prophylaxis and glaucoma. More

Effective treatment options for diseases such as Alzheimer's, Parkinson's, and cataracts are needed. This new group of compounds have the potential to treat disorders caused by oxidative stress by functioning as antioxidants and metal chelators. More

Our US based client is seeking partners for its ophthalmic product More